Taficita 200mg/25mg Tablet
| Active Ingredient (Generic Name) | Emtricitabine (200mg) + Tenofovir disoproxil fumarate (25mg) |
|---|---|
| Manufacturer | Mylan Laboratories Ltd |
| Packaging | BOTTLE |
| Strength | 200 mg |
| Delivery Time | 8 Days |
Taficita Tablet
Product Description:
Taficita Tablet is a fixed-dose combination antiretroviral medication used in the treatment of HIV-1 infection. It contains Emtricitabine and Tenofovir Disoproxil Fumarate (TDF), two potent nucleoside reverse transcriptase inhibitors (NRTIs). These active ingredients work together to block the replication of the HIV virus, thereby lowering viral load and enhancing immune function.
Taficita is typically used in combination with other antiretroviral agents as part of combination antiretroviral therapy (cART) or pre-exposure prophylaxis (PrEP), depending on clinical recommendation.
Indications:
-
HIV-1 infection in adults and adolescents
-
May also be used as part of HIV PrEP (Pre-Exposure Prophylaxis) regimens (consult physician)
Key Features:
-
Dual-action NRTI formulation
-
Trusted formulation from Mylan, a leading global pharmaceutical company
-
Supports viral suppression and reduces risk of HIV progression
-
Enhances CD4+ cell counts
-
Convenient once-daily oral dose
-
$69.00 - $99.00 -
$79.00 - $181.00
-
$59.00 - $95.00
-
$45.00 - $121.00
-
$95.00 - $200.00
-
$395.00 - $990.00
Reviews & Ratings
Taficita Tablet
Product Description:
Taficita Tablet is a fixed-dose combination antiretroviral medication used in the treatment of HIV-1 infection. It contains Emtricitabine and Tenofovir Disoproxil Fumarate (TDF), two potent nucleoside reverse transcriptase inhibitors (NRTIs). These active ingredients work together to block the replication of the HIV virus, thereby lowering viral load and enhancing immune function.
Taficita is typically used in combination with other antiretroviral agents as part of combination antiretroviral therapy (cART) or pre-exposure prophylaxis (PrEP), depending on clinical recommendation.
Indications:
-
HIV-1 infection in adults and adolescents
-
May also be used as part of HIV PrEP (Pre-Exposure Prophylaxis) regimens (consult physician)
Key Features:
-
Dual-action NRTI formulation
-
Trusted formulation from Mylan, a leading global pharmaceutical company
-
Supports viral suppression and reduces risk of HIV progression
-
Enhances CD4+ cell counts
-
Convenient once-daily oral dose
Frequently Brought Products
-
$69.00 - $99.00
-
$79.00 - $181.00
-
$59.00 - $95.00
-
$45.00 - $121.00
-
$95.00 - $200.00
-
$395.00 - $990.00
